Multidisciplinary comprehensive treatment of massive hepatocellular carcinoma with hemorrhage: A case report and review of literature

Table 1 Results for alpha-fetoprotein, ferritin, abnormal prothrombin assay, alanine aminotransferase, aspartate aminotransferase, γ-glutamyl transpeptidase, and alkaline phosphatase during the treatment and follow-up periods

	AFP (< 8.78 g/m)	FER (21.81-274.66 g/m)	PIVKA-II (13.62-40.38 AU/mL)	ALT (9-50 U/L)	AST (15-40 U/L)	γ-GT (10-60 U/L)	ALP (45-125 U/L)
POM 1	> 2000	417.69	80.53	40	21	52.33	95
POM 2	> 2000	450.84	73.78	58	52	76.2	139
POM 3	> 2000	237.77	453.92	30	25	53.1	116
POM 4	140.84	272.95	35.43	56	40	47.06	126
POM 4.5	8.11	285.44	10.81	26	17	41.4	87
POM 5	2.05	181.46	17.04	47	33	31.6	104
POM 6	1.22	225.3	33.28	63	47	65.88	110
POM 7	0.75	197.6	26.96	23	15	46	105
POM 12	52.12	0.84	20.73	64.29	32.34	70.97	125.61
POM 13	80.03	0.95	26.54	36.61	21.01	59.61	117.39

The values within the parentheses indicate the normal range for each indicator. AFP: Alpha-fetoprotein; FER: Ferritin; PIVKA-II: Abnormal prothrombin assay; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; γ-GT: γ-glutamyl transpeptidase; ALP: Alkaline phosphatase; POM: Post-operative month.